Age of vaccine administration | Name of vaccine |
---|---|
Immediate after birth | 1. BCG |
2. OPV | |
3. Hepatitis-B | |
After 6 weeks | 1. OPV-1 |
2. Penta-1 | |
3. Pneumo-1 | |
After 10 weeks | 1. OPV-2 |
2. Penta-2 | |
3. Pneumo-2 | |
After 14 weeks | 1. OPV-3 |
2. Penta-3 | |
3. Pneumo-3 | |
4. IPV | |
After 9 months | Measles-1 |
After 15 months | Measles-2 |
Parameters | Patient |
---|---|
|
|
|
100 |
Male | 48 (48%) |
Female | 52 (52%) |
|
|
Male | 15.06 (± 9.42) |
Female | 15.94 (± 9.42) |
|
|
Breastfeed | 56% |
Formula feed | 32% |
Breast + Formula | 12% |
|
|
Vaccinated (Total) | 24% |
< 12 months | (n = 2) |
12–24 months | (n = 17) |
> 24 months | (n = 5) |
Unvaccinated (Total) | 76% |
< 12 months | (n = 42) |
12–24 months | (n = 23) |
> 24 months | (n = 11) |
|
58% |
|
|
|
|
High (≥ $4,301 per annum) | 12% |
Middle (≥ $1,701 and ≤ $4,300 per annum) | 38% |
Lower (≤ $1,700 per annum) | 50% |
|
|
Higher | 7% |
Secondary | 28% |
Primary | 22% |
Uneducated | 43% |
Clinical complications | Age-wise distribution | |||
---|---|---|---|---|
< 12 months | 12–24 months | > 24 months | Total | |
Pneumonia | 23 (47.9%) | 15 (37.5%) | 3 (25%) | 41 |
LRTI | 8 (16.7) | 8 (20)% | 2 (16.7%) | 18 |
Otitis media | – | 1 (2.5%) | 1 (8.3%) | 2 |
Acute diarrhea | 4 (8.3%) | 1 (2.5%) | 1 (8.3%) | 6 |
Diarrhea + LRTI |
6 (12.5%) | 8 (20%) | 3 (25%) | 17 |
Pneumonia + Diarrhea | 3 (6.25%) | 2 (5%) | 1 (8.3%) | 6 |
Otitis media + Pneumonia | 2 (4.1%) | 1 (2.5%) | 1 (8.3%) | 4 |
Myocarditis + LRTI | 1 (2.0%) | 2 (5%) | – | 3 |
SSPE
|
– | 1 (2.5%) | – | 1 |
Pneumothorax | 1 (2.0%) | 1 (2.5%) | – | 2 |
Total | 48 | 40 | 12 | 100 |